MTOR and maternal uniparental disomy of chromosome 20: The role of the PIK3CA/AKT/mTOR axis in MBC has been demonstrated through targeted mTOR inhibition by temsirolimus, in combination with doxorubicin and bevacizumab, to improve response of MBCs, including a complete response [20].